We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 229 results
  1. Adenine base editor corrected ADPKD point mutations in hiPSCs and kidney organoids

    Autosomal dominant polycystic kidney disease (ADPKD) is a dominant genetic disorder caused primarily by mutations in the PKD1 gene, resulting in the...

    **gwen Wang, Yanling Qiu, ... Junjiu Huang in Advanced Biotechnology
    Article Open access 11 June 2024
  2. A long-read sequencing and SNP haplotype-based novel preimplantation genetic testing method for female ADPKD patient with de novo PKD1 mutation

    The autosomal dominant form of polycystic kidney disease (ADPKD) is the most common hereditary disease that causes late-onset renal cyst development...

    Cuiting Peng, Han Chen, ... Shanling Liu in BMC Genomics
    Article Open access 04 September 2023
  3. Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay

    Background

    Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic multisystem disease caused primarily by mutations in the PKD1 ...

    Xuyan Liu, **aomeng Shi, ... Ruixiao Zhang in BMC Genomics
    Article Open access 19 July 2023
  4. Kidney Disease and Proteomics: A Recent Overview of a Useful Tool for Improving Early Diagnosis

    Kidney disease is a critical and potentially life-threatening degenerative condition that poses a significant global public health challenge due to...
    Nicolly Emanuelle de Souza Barcelos, Maria Laura Limeres, ... Diogo B. Peruchetti in Mass Spectrometry-Based Approaches for Treating Human Diseases and Diagnostics
    Chapter 2024
  5. The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease

    Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and is characterized by progressive growth of...

    Abeda Jamadar, Sreenath M. Suma, ... Reena Rao in Cell Death & Disease
    Article Open access 14 October 2021
  6. Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants

    Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressively enlarging cysts. Here we elucidate the interplay between...

    Nastaran Daneshgar, Andrew W. Baguley, ... Dao-Fu Dai in Communications Biology
    Article Open access 20 October 2021
  7. Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease

    Metabolic reprogramming is emerging as a key pathological contributor to the progression of autosomal dominant polycystic kidney disease (ADPKD), but...

    Zeyun Mi, Yandong Song, ... Yupeng Chen in Nature Metabolism
    Article 13 July 2020
  8. Phosphorylation of MIF by PIP4K2a is necessary for cilia biogenesis

    Primary cilia are microtubule-based organelles that play important roles in development and tissue homeostasis. Macrophage migration inhibitory...

    Lu Zhang, Hongbing Zhang, ... **aogang Li in Cell Death & Disease
    Article Open access 05 December 2023
  9. MethylC-analyzer: a comprehensive downstream pipeline for the analysis of genome-wide DNA methylation

    DNA methylation is a crucial epigenetic modification involved in multiple biological processes and diseases. Current approaches for measuring...

    Rita Jui-Hsien Lu, Pei-Yu Lin, ... Pao-Yang Chen in Botanical Studies
    Article Open access 06 January 2023
  10. Holistic expression of miR-17-92 cluster in obesity, kidney diseases, cardiovascular diseases, and diabetes

    miR-17-92 cluster encodes six micro RNAs (miRNAs) and plays a crucial role in the regulation of various cellular processes. Aberrant expression of...

    Maheen Ejaz, Syed Mohammad Usman, ... Muhammad Jawad Khan in Molecular Biology Reports
    Article 17 June 2023
  11. Primary cilia suppress Ripk3-mediated necroptosis

    Cilia are sensory organelles that project from the surface of almost all cells. Nephronophthisis (NPH) and NPH-related ciliopathies are degenerative...

    Emilia Kieckhöfer, Gisela G. Slaats, ... Bernhard Schermer in Cell Death Discovery
    Article Open access 02 December 2022
  12. Chronic Kidney Disease: Challenges in Translational Medicine

    Chronic kidney disease (CKD) has long been recognized as a state of progressive decline in renal function. Morbidity and mortality are well...
    Bruno Freire Botelho, André Luis Barreira, ... Marcelo Marcos Morales in Gene, Drug, and Tissue Engineering
    Protocol 2023
  13. Quantitative Systems Toxicology and Drug Development: The DILIsym Experience

    DILIsym® is a Quantitative Systems Toxicology (QST) model that has been developed over the last decade by a public-private partnership to predict the...
    Paul B. Watkins in Systems Medicine
    Protocol 2022
  14. Saikosaponin-d inhibits proliferation by up-regulating autophagy via the CaMKKβ–AMPK–mTOR pathway in ADPKD cells

    Autosomal dominant polycystic kidney disease (ADPKD) is a common heritable human disease. Recently, the role of repressed autophagy in ADPKD has...

    Weiwei Shi, Dechao Xu, ... Changlin Mei in Molecular and Cellular Biochemistry
    Article 19 April 2018
  15. Role of ferroptosis in chronic kidney disease

    Chronic kidney disease (CKD) has historically been a significant global health concern, profoundly impacting both life and well-being. In the process...

    Shiyang Li, Qiuxia Han, ... Dongwei Liu in Cell Communication and Signaling
    Article Open access 12 February 2024
  16. Recent findings on the role of microRNAs in genetic kidney diseases

    Background

    MicroRNAs (miRNAs) are non-coding, endogenous, single-stranded, small (21–25 nucleotides) RNAs. Various target genes at the...

    Hassan Askari, Ehsan Raeis-Abdollahi, ... Ali Reza Safarpour in Molecular Biology Reports
    Article 18 June 2022
  17. Metabolomics: From Scientific Research to the Clinical Diagnosis

    Metabolomics supports uncovering relevant pathophysiological mechanisms and identifying biomarkers of risk and progression in diseases. Furthermore,...
    E. A. Estrella-Parra, A. M. Espinosa-González, ... J. G. Avila-Acevedo in Principles of Genetics and Molecular Epidemiology
    Chapter 2022
  18. Changes of urine isolates of Escherichia coli and Klebsiella pneumoniae biofilm affect monocytes’ response

    The Gram negative rods as Escherichia coli and Klebsiella pneumoniae belong to the most common etiology agents of urinary tract infections. The aim...

    Agnieszka Daca, Justyna Gołębiewska, ... Tomasz Jarzembowski in World Journal of Microbiology and Biotechnology
    Article Open access 28 September 2021
  19. Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry

    Background

    Halting progression of chronic kidney disease (CKD) to established end stage kidney disease is a major goal of global health research. The...

    Carlos R. Ramírez Medina, Ibrahim Ali, ... Nophar Geifman in Clinical Proteomics
    Article Open access 20 April 2023
  20. Investigation of APE1 and OGG1 expression in chronic hemodialysis patients

    Background

    The role of DNA repair mechanisms is of significant importance in diseases characterized by elevated oxidative DNA damage, such as chronic...

    Manouchehr Rostami, Serkan Feyyaz Yalin, ... Mehmet Guven in Molecular Biology Reports
    Article 18 January 2024
Did you find what you were looking for? Share feedback.